• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射生物学与辐射防护

Radiation biology and radiation protection.

作者信息

Hendry J H

机构信息

Adlington, Macclesfield, UK.

出版信息

Ann ICRP. 2012 Oct-Dec;41(3-4):64-71. doi: 10.1016/j.icrp.2012.06.013. Epub 2012 Aug 22.

DOI:10.1016/j.icrp.2012.06.013
PMID:23089005
Abstract

For protection purposes, the biological effects of radiation are separated into stochastic effects (cancer, hereditary effects) presumed to be unicellular in origin, and tissue reactions due to injury in populations of cells. The latter are deterministic effects, renamed 'tissue reactions' in the 2007 Recommendations of the International Commission on Radiological Protection because of the increasing evidence of the ability to modify responses after irradiation. Tissue reactions become manifest either early or late after doses above a threshold dose, which is the basis for recommended dose limits for avoiding such effects. Latency time before manifestation is related to cell turnover rates, and tissue proliferative and structural organisation. Threshold doses have been defined for practical purposes at 1% incidence of an effect. In general, threshold doses are lower for longer follow-up times because of the slow progression of injury before manifestation. Radiosensitive individuals in the population may contribute to low threshold doses, and in the future, threshold doses may be increased by the use of various biological response modifiers post irradiation for reducing injury. Threshold doses would be expected to be higher for fractionated or protracted doses, unless doses below the threshold dose only cause single-hit-type events that are not modified by repair/recovery phenomena, or if different mechanisms of injury are involved at low and high doses.

摘要

出于防护目的,辐射的生物学效应被分为随机性效应(癌症、遗传效应),这类效应被认为起源于单细胞,以及细胞群体损伤导致的组织反应。后者为确定性效应,在国际放射防护委员会2007年的建议中被重新命名为“组织反应”,因为越来越多的证据表明照射后反应具有可调节性。在高于阈剂量的情况下,组织反应会在早期或晚期显现出来,这是推荐用于避免此类效应的剂量限值的依据。显现前的潜伏期与细胞更新率、组织增殖和结构组织有关。出于实际目的,阈剂量被定义为效应发生率为1%时的剂量。一般来说,由于显现前损伤进展缓慢,随访时间越长阈剂量越低。人群中的辐射敏感个体可能导致阈剂量较低,并且在未来,照射后使用各种生物反应调节剂来减轻损伤可能会提高阈剂量。分次或延长剂量的阈剂量预计会更高,除非低于阈剂量的剂量仅引起不会因修复/恢复现象而改变的单次打击型事件,或者在低剂量和高剂量下涉及不同的损伤机制。

相似文献

1
Radiation biology and radiation protection.放射生物学与辐射防护
Ann ICRP. 2012 Oct-Dec;41(3-4):64-71. doi: 10.1016/j.icrp.2012.06.013. Epub 2012 Aug 22.
2
ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.国际放射防护委员会第118号出版物:国际放射防护委员会关于正常组织和器官中辐射的组织反应及早期和晚期效应的声明——辐射防护背景下组织反应的阈值剂量
Ann ICRP. 2012 Feb;41(1-2):1-322. doi: 10.1016/j.icrp.2012.02.001.
3
Threshold doses and circulatory disease risks.阈剂量与循环系统疾病风险。
Ann ICRP. 2015 Jun;44(1 Suppl):69-75. doi: 10.1177/0146645314560688. Epub 2015 Mar 17.
4
[Basis of radiation protection].[辐射防护的基础]
Schweiz Med Wochenschr. 1996 Jun 29;126(26):1157-71.
5
New ICRP recommendations.国际放射防护委员会新建议。
J Radiol Prot. 2008 Jun;28(2):161-8. doi: 10.1088/0952-4746/28/2/R02. Epub 2008 May 22.
6
Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.在发生放射性袭击时保护人们免受辐射照射。国际放射防护委员会的一份报告。
Ann ICRP. 2005;35(1):1-110, iii-iv. doi: 10.1016/j.icrp.2005.01.001.
7
Dose quantities in radiation protection and their limitations.辐射防护中的剂量量及其限制。
Radiat Prot Dosimetry. 2004;112(4):457-63. doi: 10.1093/rpd/nch097.
8
Radiation and your patient: a guide for medical practitioners.辐射与您的患者:医学从业者指南
Ann ICRP. 2001;31(4):5-31.
9
Radar commentary: Use of linear no-threshold hypothesis in radiation protection regulation in the United States.雷达评论:美国辐射防护法规中线性无阈值假设的应用。
Health Phys. 2012 Jan;102(1):90-9. doi: 10.1097/HP.0b013e318228e5b4.
10
Global nuclear industry views: challenges arising from the evolution of the optimisation principle in radiological protection.全球核工业观点:辐射防护中优化原则演变带来的挑战。
Ann ICRP. 2012 Oct-Dec;41(3-4):275-81. doi: 10.1016/j.icrp.2012.07.003. Epub 2012 Sep 12.

引用本文的文献

1
Prevalence of Lens Opacity in Interventional Cardiologists and Professional Working in the Hemodynamics in Brazil.巴西介入心脏病学家和血液动力学专业人员晶状体混浊的患病率。
Arq Bras Cardiol. 2019 Apr;112(4):392-399. doi: 10.5935/abc.20190028. Epub 2019 Feb 21.
2
Radiation exposure, the forgotten enemy: Toward implementation of national safety program.辐射暴露,被遗忘的敌人:迈向国家安全计划的实施
Egypt Heart J. 2017 Mar;69(1):55-62. doi: 10.1016/j.ehj.2016.10.001. Epub 2016 Nov 15.
3
Perception of low dose radiation risks among radiation researchers in Korea.
韩国放射研究人员对低剂量辐射风险的认知
PLoS One. 2017 Feb 6;12(2):e0171777. doi: 10.1371/journal.pone.0171777. eCollection 2017.
4
Radiation Exposures Associated With Radial and Femoral Coronary Interventions.与桡动脉和股动脉冠状动脉介入相关的辐射暴露
Curr Treat Options Cardiovasc Med. 2016 Dec;18(12):73. doi: 10.1007/s11936-016-0499-x.
5
Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance.不断发展的临床肿瘤放射治疗:关于正常组织保护和质量保证的问题
J Korean Med Sci. 2016 Feb;31 Suppl 1(Suppl 1):S75-87. doi: 10.3346/jkms.2016.31.S1.S75. Epub 2016 Jan 28.
6
Mutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy.接受放疗的癌症患者中人类干扰素α-2b(hIFNα-2b)基因的突变
Am J Cancer Res. 2015 Jul 15;5(8):2455-66. eCollection 2015.
7
Radiation in medicine: Origins, risks and aspirations.医学中的辐射:起源、风险与展望。
Glob Cardiol Sci Pract. 2014 Dec 31;2014(4):437-48. doi: 10.5339/gcsp.2014.57. eCollection 2014.